Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Open Labeled Trial of Isoniazid Treatment Based on ELISPOT Assay to Prevent Tuberculosis in a Kidney Transplant Recipient

NCT01087190 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01087190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01087190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Open Labeled Trial of Isoniazid Treatment Based on ELISPOT Assay to Prevent Tuberculosis in a Kidney Transplant Recipient
Lead sponsor
Asan Medical Center
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2010
Completion date
November 30, 2013
Enrollment
831 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant recipient